Novartis Aktie
WKN: 904278 / ISIN: CH0012005267
|
08.07.2025 07:14:46
|
Press Release: Novartis receives approval for -2-
References
1. Eight African countries participated in Swissmedic's Marketing
Authorization for Global Health Products (MAGHP) procedure
https://www.swissmedic.ch/swissmedic/en/home/about-us/development-cooperation/marketing-authorisation-for-global-health-products.html
for Coartem Baby -- Burkina Faso, Cote d'Ivoire, Kenya, Malawi,
Mozambique, Nigeria, Tanzania and Uganda -- and are expected to approve
the medicine following approval by Swissmedic. These eight countries
account for 47% of estimated cases in 2023, according to the WHO's Global
Health Observatory
https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-number-of-malaria-deaths
2. WHO. Malaria vaccines (RTS,S and R21)
https://www.who.int/news-room/questions-and-answers/item/q-a-on-rts-s-malaria-vaccine#::text=Malaria%20vaccines%20should%20be%20provided%20to%20children%20in%20a%20schedule,
age%20based%20on%20operational%20considerations.
3. Reddy, Valentina et al. Global estimates of the number of pregnancies at
risk of malaria from 2007 to 2020: a demographic study. The Lancet Global
Health, Volume 11, Issue 1, e40 - e47
4. Ceesay SJ et al. Malaria Prevalence among Young Infants in Different
Transmission Settings, Africa. Emerg Infect Dis. 2015 Jul;21(7):1114-21.
doi: 10.3201/eid2107.142036. PMID: 26079062; PMCID: PMC4480393.
5. D'Alessandro U, et al. Malaria in infants aged less than six months - is
it an area of unmet medical need? Malar J. 2012 Dec 2;11:400. doi:
10.1186/1475-2875-11-400. PMID: 23198986; PMCID: PMC3529680.
6. Dobbs, et al. Plasmodium malaria and antimalarial antibodies in the first
year of life. Parasitology. 2016;143(2):129-138.
doi:10.1017/S0031182015001626
7. WHO. Malaria. https://www.who.int/news-room/fact-sheets/detail/malaria
# # #
Novartis Media Relations
E-mail: media.relations@novartis.com
Novartis Investor Relations
Central investor relations line: +41 61 324 7944
E-mail: investor.relations@novartis.com
(END) Dow Jones Newswires
July 08, 2025 01:15 ET (05:15 GMT)
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Novartis AG
|
09:29 |
Dienstagshandel in Europa: STOXX 50-Börsianer greifen zum Start zu (finanzen.at) | |
|
09:29 |
Börse Zürich in Grün: SLI verbucht zum Handelsstart Zuschläge (finanzen.at) | |
|
09:29 |
Börse Zürich: SMI beginnt Handel mit Gewinnen (finanzen.at) | |
|
29.06.26 |
Angespannte Stimmung in Europa: STOXX 50 notiert am Mittag im Minus (finanzen.at) | |
|
29.06.26 |
SMI-Handel aktuell: SMI liegt am Mittag im Minus (finanzen.at) | |
|
29.06.26 |
Angespannte Stimmung in Europa: STOXX 50 zum Start in Rot (finanzen.at) | |
|
25.06.26 |
Börse Europa in Grün: STOXX 50 schlussendlich freundlich (finanzen.at) | |
|
25.06.26 |
SMI-Handel aktuell: SMI verbucht am Mittag Zuschläge (finanzen.at) |
Analysen zu Novartis AG
| 25.06.26 | Novartis Buy | Deutsche Bank AG | |
| 11.06.26 | Novartis Hold | Jefferies & Company Inc. | |
| 09.06.26 | Novartis Buy | Deutsche Bank AG | |
| 04.06.26 | Novartis Hold | Jefferies & Company Inc. | |
| 27.05.26 | Novartis Buy | Deutsche Bank AG |
Aktien in diesem Artikel
| Novartis AG | 138,26 | 0,44% |
|
| Novartis AG (Spons. ADRS) | 137,00 | 0,00% |
|